Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire

Ruth A. Ettinger, Pedro Paz, Eddie A. James, Devi Gunasekera, Fred Aswad, Arthur R. Thompson, Dana C. Matthews, Kathleen P. Pratt

Blood (2016) 128 (16): 2043–2054.

https://doi.org/10.1182/blood-2015-11-682468

Published: 2016

Includes: Supplemental data

Journal Articles

Factor VIII gene variants and inhibitor risk in African American hemophilia A patients

Devi Gunasekera, Ruth A. Ettinger, Shelley Nakaya Fletcher, Eddie A. James, Maochang Liu, John C. Barrett, Janice Withycombe, Dana C. Matthews, Melinda S. Epstein, Richard J. Hughes, Kathleen P. Pratt

Blood (2015) 126 (7): 895–904.

https://doi.org/10.1182/blood-2014-09-599365

Published: 2015

Includes: Supplemental data

Journal Articles

Factor VIII Gene Variants and Inhibitor Risk in African American Hemophilia a Patients

Devi Gunasekera, MD, Ruth A. Ettinger, PhD, Shelley Nakaya Fletcher, B.S., Eddie A. James, PhD, Maochang Liu, PhD, John C. Barrett, MD, Janice Withycombe, PhD, R.N., M.N., C.C.R.P., Dana C. Matthews, MD, Melinda S. Epstein, PhD, Richard J. Hughes, PhD, Kathleen P. Pratt, PhD

Blood (2014) 124 (21): 235.

https://doi.org/10.1182/blood.V124.21.235.235

Published: 2014

Journal Articles

PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)

Blood (2014) 124 (21): 1450.

https://doi.org/10.1182/blood.V124.21.1450.1450

Published: 2014

Journal Articles

Factor VIII Proteins Having a Rationally Modified, Immunodominant T-Cell Epitope Demonstrate Normal Procoagulant Activity, Bind To VWF With High Affinity, and Are Markedly Less Stimulatory To FVIII-Specific Human T Cells

Ruth A. Ettinger, Ph.D., Eddie A. James, Ph.D., Komal Puranik, M.Sc., Arthur R. Thompson, M.D., Ph.D., Dana C. Matthews, M.D., Kathleen P. Pratt, Ph.D.

Blood (2013) 122 (21): 574.

https://doi.org/10.1182/blood.V122.21.574.574

Published: 2013

Journal Articles

Sequence-Modified Factor VIII Variants Having Reduced Immunogenicity

Ruth A. Ettinger, PhD, Melinda S. Epstein, PhD, Komal Puranik, MSc, Richard J. Hughes, PhD, Joseph A Liberman, BS, Eddie James, Ph.D., Tom E. Howard, MD, PhD, Shelley S. Cole, Ph.D., Dana C. Matthews, MD, Kathleen P. Pratt, PhD

Blood (2012) 120 (21): 39.

https://doi.org/10.1182/blood.V120.21.39.39

Published: 2012

Journal Articles

Antithrombin Concentrate Use in Pediatric Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study

Trisha E. Wong, MD, Meghan Delaney, DO, MPH, Terry B. Gernsheimer, MD, Dana C. Matthews, MD, Tom Brogan, MD, Rob Mazor, MD, D. Michael McMullan, MD, Alexander P Reiner, MD, MSC, Barbara A. Konkle, MD

Blood (2012) 120 (21): 1170.

https://doi.org/10.1182/blood.V120.21.1170.1170

Published: 2012

Journal Articles

Determination of Anti-Factor VIIII Antibody Titers, Isotypes and Epitopes by SPR Analysis of Human Plasma

Kenneth B Lewis, Ph.D., Phuong-Cac Nguyen, Ph.D., Jason T. Schuman, Ph.D., Christopher E. Walsh, MD, PhD, Neil C. Josephson, MD, Tom E. Howard, MD, PhD, Dana C. Matthews, MD, Nigel S. Key, MBChB, Kathleen P. Pratt, Ph.D.

Blood (2011) 118 (21): 202.

https://doi.org/10.1182/blood.V118.21.202.202

Published: 2011

Journal Articles

Allogeneic hematopoietic cell transplantation after conditioning with 131 I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

John M. Pagel, Theodore A. Gooley, Joseph Rajendran, Darrell R. Fisher, Wendy A. Wilson, Brenda M. Sandmaier, Dana C. Matthews, H. Joachim Deeg, Ajay K. Gopal, Paul J. Martin, Rainer F. Storb, Oliver W. Press, Frederick R. Appelbaum

Blood (2009) 114 (27): 5444–5453.

https://doi.org/10.1182/blood-2009-03-213298

Published: 2009

Journal Articles

131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission

John M. Pagel, Frederick R. Appelbaum, Janet F. Eary, Joseph Rajendran, Darrell R. Fisher, Ted Gooley, Katherine Ruffner, Eneida Nemecek, Eileen Sickle, Larry Durack, Jeanette Carreras, Mary M. Horowitz, Oliver W. Press, Ajay K. Gopal, Paul J. Martin, Irwin D. Bernstein, Dana C. Matthews

Blood (2006) 107 (5): 2184–2191.

https://doi.org/10.1182/blood-2005-06-2317

Published: 2006

Journal Articles

131 I-Anti-CD45 Antibody Plus Fludarabine, Low-Dose Total Body Irradiation and Peripheral Blood Stem Cell Infusion for Elderly Patients with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).

John M. Pagel, MD, PhD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD, Joseph G. Rajendran, MD, Ted Gooley, PhD, Darrell R. Fisher, PhD, Eneida Nemecek, MD, Ajay K. Gopal, MD, Michael B. Maris, MD, Katherine Ruffner, MD, Dana C. Matthews, MD, H. Joachim Deeg, MD, David G. Maloney, MD, PhD, Paul J. Martin, MD, Rainer Storb, MD

Blood (2005) 106 (11): 397.

https://doi.org/10.1182/blood.V106.11.397.397

Published: 2005

Journal Articles

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

John M. Pagel, MD, PhD, Frederick R. Appelbaum, MD, Janet F. Eary, MD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Ted Gooley, PhD, Eneida Nemecek, MD, Katherine Ruffner, MD, Eileen Sickle, RN, Larry Durack, CNMT, Jeanette Carreras, MPH, Mary M. Horowitz, MD, MS, Ajay K. Gopal, MD, Oliver W. Press, MD, PhD, Paul J. Martin, MD, Irwin D. Bernstein, MD, Dana C. Matthews, MD

Blood (2004) 104 (11): 813.

https://doi.org/10.1182/blood.V104.11.813.813

Published: 2004

Journal Articles

A Myeloablative Regimen Incorporating Radiolabeled Anti-CD45 (BC8) Antibody Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Advanced Acute Myeloid Leukemia (AML).

Eneida R. Nemecek, MD, John M. Pagel, MD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Frederick R. Appelbaum, MD, Oliver W. Press, MD, PhD, Dana C. Matthews, MD

Blood (2004) 104 (11): 828.

https://doi.org/10.1182/blood.V104.11.828.828

Published: 2004

Journal Articles

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis

Ajay K. Gopal, Theodore A. Gooley, David G. Maloney, Stephen H. Petersdorf, Janet F. Eary, Joseph G. Rajendran, Sharon A. Bush, Lawrence D. Durack, Jane Golden, Paul J. Martin, Dana C. Matthews, Frederick R. Appelbaum, Irwin D. Bernstein, Oliver W. Press

Blood (2003) 102 (7): 2351–2357.

https://doi.org/10.1182/blood-2003-02-0622

Published: 2003

Journal Articles

Rituximab in the very young: benefits in AIHA, at what risk?

Dana C. Matthews

Blood (2003) 101 (10): 3761.

https://doi.org/10.1182/blood-2003-03-0834

Published: 2003

Journal Articles

Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas

John M. Pagel, Nathan Hedin, Krishnan Subbiah, Damon Meyer, Robert Mallet, Donald Axworthy, Louis J. Theodore, D. Scott Wilbur, Dana C. Matthews, Oliver W. Press

Blood (2003) 101 (6): 2340–2348.

https://doi.org/10.1182/blood-2002-03-0874

Published: 2003

Journal Articles

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

Ajay K. Gopal, Joseph G. Rajendran, Stephen H. Petersdorf, David G. Maloney, Janet F. Eary, Brent L. Wood, Theodore A. Gooley, Sharon A. Bush, Lawrence D. Durack, Paul J. Martin, Dana C. Matthews, Frederick R. Appelbaum, Irwin D. Bernstein, Oliver W. Press

Blood (2002) 99 (9): 3158–3162.

https://doi.org/10.1182/blood.V99.9.3158

Published: 2002

Journal Articles

A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas

Oliver W. Press, Janet F. Eary, Ted Gooley, Ajay K. Gopal, Stephen Liu, Joseph G. Rajendran, David G. Maloney, Stephen Petersdorf, Sharon A. Bush, Lawrence D. Durack, Paul J. Martin, Darrell R. Fisher, Brent Wood, James W. Borrow, Bruce Porter, Justin P. Smith, Dana C. Matthews, Frederick R. Appelbaum, Irwin D. Bernstein

Blood (2000) 96 (9): 2934–2942.

https://doi.org/10.1182/blood.V96.9.2934

Published: 2000

Journal Articles

Phase I Study of 131 I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome

Dana C. Matthews, Frederick R. Appelbaum, Janet F. Eary, Darrell R. Fisher, Lawrence D. Durack, T. Edmond Hui, Paul J. Martin, David Mitchell, Oliver W. Press, Rainer Storb, Irwin D. Bernstein

Blood (1999) 94 (4): 1237–1247.

https://doi.org/10.1182/blood.V94.4.1237

Published: 1999

Journal Articles

Marrow Ablative and Immunosuppressive Effects of 131 I-Anti-CD45 Antibody in Congenic and H2-Mismatched Murine Transplant Models

Dana C. Matthews, Paul J. Martin, Cynthia Nourigat, Frederick R. Appelbaum, Darrell R. Fisher, Irwin D. Bernstein

Blood (1999) 93 (2): 737–745.

https://doi.org/10.1182/blood.V93.2.737

Published: 1999

NARROW

T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire

Factor VIII gene variants and inhibitor risk in African American hemophilia A patients

Factor VIII Gene Variants and Inhibitor Risk in African American Hemophilia a Patients

PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)

Factor VIII Proteins Having a Rationally Modified, Immunodominant T-Cell Epitope Demonstrate Normal Procoagulant Activity, Bind To VWF With High Affinity, and Are Markedly Less Stimulatory To FVIII-Specific Human T Cells

Sequence-Modified Factor VIII Variants Having Reduced Immunogenicity

Antithrombin Concentrate Use in Pediatric Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study

Determination of Anti-Factor VIIII Antibody Titers, Isotypes and Epitopes by SPR Analysis of Human Plasma

Allogeneic hematopoietic cell transplantation after conditioning with 131 I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission

131 I-Anti-CD45 Antibody Plus Fludarabine, Low-Dose Total Body Irradiation and Peripheral Blood Stem Cell Infusion for Elderly Patients with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

A Myeloablative Regimen Incorporating Radiolabeled Anti-CD45 (BC8) Antibody Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Advanced Acute Myeloid Leukemia (AML).

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis

Rituximab in the very young: benefits in AIHA, at what risk?

Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas

Phase I Study of 131 I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome

Marrow Ablative and Immunosuppressive Effects of 131 I-Anti-CD45 Antibody in Congenic and H2-Mismatched Murine Transplant Models

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only